[The ilio-femoral approach: an alternative for implanting permanent cardiac pacemakers. Three case reports]. / La voie ilio-fémorale: une alternative pour l'implantation de sondes de stimulation cardiaque définitives. A propos de trois cas.

Permanent endocavitary cardiac pacing is a widely used therapeutic method. The implantation of pacing catheters is usually performed by the supracardiac veins, the epicardial approach being the classical alternative. The ilio-femoral approach is a third possibility. The authors report three cases in which this approach was used. The implantations were performed under general anaesthesia with an abdominal pacemaker. In two cases, atrial and ventricular catheters were implanted. After an average of 19 months' follow-up, no short or long-term complications were observed: displacement or fracture of the pacing catheter, infection, venous thrombosis, threshold elevation. These results show that this is a safe and feasible alternative to implantation by the traditional or epicardial techniques when these approaches cannot be used.

Long-term evaluation of autonomic tone in patients below 50 years of age with unexplained cerebral infarction: relation to atrial vulnerability.

UNLABELLED: Preliminary studies have described, in young patients with unexplained cerebral infarction, electrophysiological abnormalities similar to those observed in paroxysmal atrial fibrillation. Moreover, in young adults with 'normal' hearts, increased susceptibility to paroxysmal atrial fibrillation with autonomic abnormalities as assessed by heart rate variability analysis have been reported. METHODS: The long-term time and frequency domain measures of heart rate variability were analysed prospectively from 24-h Holter ECG recordings in 25 patients (39 +/- 8 years) with unexplained cerebral infarction, and in 25 age-, sex- and cigarette-smoking-matched healthy control subjects. The day following the Holter ECG recordings, 9 +/- 4 months (mean) after the stroke, stroke patients underwent an electrophysiological study in order to analyse the electrical characteristics of their right atria and also to determine their vulnerability to atrial fibrillation. The correlations between autonomic tone parameters and electrophysiological findings were therefore assessed with linear regression analyses. RESULTS: All the measured components of heart rate variability either in time (SDNN, pNN50, SDANN/5, rMSSD) or frequency domains (total power, low-frequency, high-frequency power, low-frequency/high-frequency power ratio) were similar between stroke patients and controls. During electrophysiological study, atrial fibrillation was induced in 80% of stroke patients. Among these patients, atrial refractory periods were significantly shorter, local electrograms were longer, and latent atrial vulnerability index was markedly decreased when compared with patients having no inducible atrial fibrillation. Concerning heart rate variability analysis, no difference was found between patients with induced atrial fibrillation when compared with a matched subgroup of healthy control subjects. Furthermore, there was no statistically linear correlation between any of the measured autonomic tone parameters and any of the discovered atrial vulnerability markers. CONCLUSIONS: The long-term autonomic tone parameters of young patients presenting with a history of unexplained cerebral infarction are similar to those of healthy control subjects and are not correlated with atrial vulnerability parameters or atrial fibrillation inducibility.

[Determinants of survival after implantation of an automatic defibrillator. Report of 127 patients]. / Déterminants de la survie après implantation d'un défibrillateur automatique implantable. A propos de 127 patients.

The authors present a retrospective and longitudinal study of the predictive factors of mortality in patients having an implanted automatic defibrillator. The population comprised 127 patients implanted between September 1988 and September 1997. There were 107 men with a mean age of 57.7 +/- 13 years. The left ventricular ejection fraction was 39.3%. The proportion of coronary patients was 68%; 20% of patients had atrial fibrillation and 5% were in Class III of the NYHA classification. The indications were: resuscitated cardiac arrest (N = 56) and poorly tolerated ventricular tachycardia (N = 71). The follow-up period was 30 +/- 25 months. There were 23 early and 10 late complications. Seventy-two patients had received an electric shock; 57 had an appropriate shock. There were 23 arrhythmic storms (ventricular arrhythmia requiring at least 2 shocks in less than 24 hours) in 17 patients. The operative mortality was 1.1%; at 1 year, the global survival was 93.9 +/- 2.2%; cardiac survival was 94.7 +/- 2.1%; survival without sudden death was 98.3 +/- 1.2%. Multivariate analysis isolated predictive factors for mortality; atrial fibrillation was predictive for global mortality; an ejection fraction < 30% and the fact of having received an appropriate shock were predictive of cardiac mortality; and an arrhythmic storm was predictive of sudden death.

[Infections secondary to the implantation of a pacemaker: update]. / Infections secondaires à l'implantation d'un stimulateur cardiaque: mise au point.

Pacemaker lead infection is a major complication of endovascular permanent pacing. The incidence is less than 1% but it is a frequent disease due to the high number of pacemaker implanted. The diagnosis is difficult due to the insidious symptoms. Pacemaker infection must be systematically considered in patients with a pacemaker and symptoms of infection. Several investigations are useful for the diagnosis particularly the transesophageal echocardiography, but all investigations have a low negative predictive value. All of the implanted material must be completely removed.

Single center experience with femoral extraction of permanent endocardial pacing leads.

Between March 1995 and June 1997, 128 leads were extracted from the hearts of 28 women and 50 men, 69 +/- 15 years of age (mean +/- SD, range 22-92 years). The indications for the procedure were: Accufix leads in 18 patients (14%), dysfunction or incompatibility with ICD in 16 (12%), endocarditis on the lead in 41 (32%), pulse generator pocket infection in 28 (22%), and pulse generator and/or lead erosion in 25 patients (19%). The extraction was performed with a snare (lasso), via a femoral vein as a first approach in 116 leads, and as an alternate approach, after extraction from the original site of implantation had failed, in 12 leads. The leads had been implanted for 62 +/- 48 months (range 1-205 months). A Cook sheath was used in 7, and a femoral approach traction in 20 instances. Of the 128 leads, 122 (95%) were completely extracted, and 2 (2%) were partially extracted (the distal electrode remaining attached to the myocardium), and 4 (3%) could not be removed. Four complications occurred: 2 tears of the tricuspid valve without clinical consequences, one separation of the lead's distal electrode which migrated into the hypogastric vein, and one hemorrhage at the femoral puncture site. There was no death or serious complication caused by lead extraction in this series.

Inadequate sympathovagal balance in response to orthostatism in patients with unexplained syncope and a positive head up tilt test.

AIM: To analyse the immediate response of heart rate variability (HRV) in response to orthostatic stress in unexplained syncope. SUBJECTS: 69 subjects, mean (SD) age 42 (18) years, undergoing 60 degrees head up tilt to evaluate unexplained syncope. METHODS: Based on 256 second ECG samples obtained during supine and upright phases, spectral analyses of low (LF) and high frequency (HF) bands were calculated, as well as the LF/HF power ratio, reflecting the sympathovagal balance. All variables were measured just before tilt during the last five minutes of the supine position, during the first five minutes of head up tilt, and just before the end of passive tilt. RESULTS: Symptoms occurred in 42 subjects (vasovagal syncope in 37; psychogenic syncope in five). Resting haemodynamics and HRV indices were similar in subjects with and without syncope. Immediately after assuming the upright posture, adaptation to orthostatism differed between the two groups in that the LF/HF power ratio decreased by 11% from supine (from 2.7 (1.5) to 2.4 (1.2)) in the positive test group, while it increased by 11.5% (from 2.8 (1.5) to 3.1 (1.7)) in the negative test group (p = 0.02). This was because subjects with a positive test did not have the same increment in LF power with tilting as those with a negative test (11% v 28%, p = 0.04), while HF power did not alter. A decreased LF/HF power ratio persisted throughout head up tilt and was the only variable found to discriminate between subjects with positive and negative test results (p = 0.005, multivariate analysis). During the first five minutes of tilt, a decreased LF/HF power ratio occurred in 33 of 37 subjects in the positive group and three of 27 in the negative group. Thus a decreased LF/HF ratio had 89% sensitivity, 89% specificity, a 92% positive predictive value, and an 86% negative predictive value. CONCLUSIONS: Through the LF/HF power ratio, spectral analysis of HRV was highly correlated with head up tilt results. Subjects developing syncope late during continued head up tilt have a decrease in LF/HF ratio immediately after assuming the upright posture, implying that although symptoms have not developed the vasovagal reaction may already have begun. This emphasises the major role of the autonomic nervous system in the genesis of vasovagal (neurally mediated) syncope.

Extraction of endocardial implantable cardioverter-defibrillator leads.

Despite a growing number of implantable cardioverter-defibrillator (ICD) lead removal indications, there is no consensus about extraction techniques. We applied our experience of pacemaker lead removal to ICD leads using a superior approach with a standard extractor kit, and an inferior approach with a lasso, or a surgical extraction. Fifteen leads were removed in 11 patients during 12 procedures (1 patient was referred twice): 11 right ventricular defibrillation leads, 3 right atrial coils, and 1 atrial lead implanted with a DDD-ICD. The indication for lead extraction was insulation failure (n = 4), conductor fracture (n = 2), abdominal pocket infection (n = 4), lead endocarditis (n = 1), and replacement of an atrial coil by an atrial lead for DDD-R pacing (n = 1). One patient had surgical extraction of 2 leads because of an endocarditis with large vegetations on a DDD-ICD. In 11 other cases, 5 leads were removed using a superior approach with a standard extraction kit and 8 leads were removed by a femoral approach using a lasso alone or added to a pigtail catheter. There was no failure of explantation. One extraction attempt failed with the superior approach but was successful with a secondary inferior approach. The main difficulties encountered were due to tight adherence of the proximal coil to the venous wall and to dislodgment of passive fixation leads from their endocardial insertion. One patient had subclavian vein thrombosis after intervention; no major complication was noted. Ten patients immediately underwent reimplantation. Two patients (1 with an endocarditis and 1 free of ICD therapy for 5 years) did not have reimplantation. During a 4- to 44-month follow-up, no late complication appeared. Thus, ICD lead explantation can be performed with a good success rate, with extraction techniques similar to those used for pacemaker leads.

Ventricular tachycardia originating from the posteroseptal process of the left ventricle with inferior wall healed myocardial infarction.

Ventricular tachycardia (VT) substrates may form in preferential locations and similar electrocardiographic patterns may be observed when ventricular activation starts from a particular site. We examined the role of the posterior inferior process of the left ventricle in the mechanism of VT occurring after inferior wall myocardial infarction. We reviewed isochronal maps of 40 VTs obtained at surgery in 13 patients, with a 128-electrode system using epicardial sock and endocardial balloon electrode arrays. Based on the epicardial to left endocardial relation we observed 7 tachycardias in 7 patients with onset of activation over the crux of the heart. This activation mimicked excitation through a posteroseptal accessory pathway. Endocardial activation maps showed breakthroughs occurring 6 to 40 ms later and did not give evidence in favor of macroreentry. In all but 1 VT, left-axis deviation was present (-30 to -75 degrees) with a positive concordance from leads V2 to V6 (QRS wave patterns were variable in V1). These tachycardias, which were clinical in 3 of 7 cases, were interpreted as arising from the posterior inferior process of the left ventricle and successfully ablated by left septal and epicardial cryolesions. In another patient, this concept was further validated by percutaneous radiofrequency ablation of a tachycardia with the previously described morphology. In conclusion, VT may originate from the posteroseptal process of the left ventricle with inferior wall healed myocardial infarction. Because these tachycardias can be successfully eliminated, their characteristic morphologies may provide clinical markers for the identification of patient candidates to surgical or nonsurgical ablative therapy.

Extraction and reimplantation of defibrillation leads through a thrombotic subclavian vein.

Venous thrombosis is one of the most frequently encountered obstacles when reintervening on endocardial leads. We report on two patients with a ventricular defibrillator requiring lead replacement in whom a subclavian vein thrombosis was documented prior to the intervention. We recanalized the vein and replaced the lead through the same path to preserve the venous access.

Triple chamber pacemaker for end-stage heart failure in a patient with a previously implanted automatic defibrillator.

A 63-year-old man with an ischemic dilated cardiomyopathy previously implanted with an implantable cardioverter defibrillator (ICD) received a triple chamber pacemaker as an ultimate therapeutic resort for end-stage congestive heart failure. After implant, the tolerance to physical exercise increased and NYHA class decreased from III to II. Echocardiography assessed ventricular contraction resynchronization during DDD biventricular pacing as compared to VVI pacing. No major pacemaker-ICD interaction was noted during testing or follow-up. We conclude that sequential biventricular pacing is feasible in the presence of an ICD.

[Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases]. / Le défibrillateur automatique implantable double chambre. Expérience à propos de 16 cas.

In view of the large number of inappropriate shocks observed in patients with implanted defibrillators, improved detection of ventricular arrhythmias has become a major objective. The addition of an atrial catheter has been proposed to improve discrimination between ventricular and non-ventricular arrhythmias. Besides this function, the additional catheter could be used for DDD pacing without risk of interaction between the pacemaker and defibrillator. The authors report their initial experience in 16 patients implanted with a DDD pacemaker. The indication was resuscitated sudden death (N = 5) or ventricular tachycardia (N = 11). The choice of a DDD defibrillator was justified by a bradycardia (N = 9), haemodynamic factors (N = 4) or supraventricular tachycardia (N = 3). The devices used were the Defender 9001 (ELA Medical SA, France, N = 3), the Ventak AV 1810 and the Ventak AV II DR 1821 (Guidant/CPI, Inc. USA, N = 11 and N = 2 respectively). There were three immediate complications. After 2 to 29 months' follow-up, 5 patients had received appropriate treatment by their devices. Five patients had inappropriate shocks : one patient received a shock triggered by electrical interference, two others had no active sensing algorithme when the shocks were delivered, and the other two had an activated algorithme with 1/1 conduction of a supraventricular arrhythmia. No recurrences were recorded after reprogramming the device. DDD or VDD pacing was permanent in 9 patients and intermittent in 3 others. Seven patients had dilated cardiomyopathy and severe cardiac failure and were clinically improved by dual chamber pacing. In many patients, candidates for a defibrillator, this new generation of devices has improved specificity of arrhythmia detection and cardiac pacing without risk of interaction. The authors propose a classification of the indications for a DDD defibrillator.

[VDD mode single electrode cardiac stimulation: indications, results and limitations of the method]. / La stimulation cardiaque en mode VDD à sonde unique: indications, résultats et limites de la méthode.

UNLABELLED: Several authors have reported the single atrioventricular (AV) electrode, comprising an atrial dipole floating in the right atrium, to be a system capable of providing results which are just as satisfactory as those of conventional systems (DDD). Between August 1992 and March 1995, a VDD single electrode pacemaker was implanted in 65 patients (mean age: 73 years +/- 17.2). The indication for implantation was isolated high degree AVB with no apparent sinus dysfunction. Four pacemakers were used: Vitatron (n = 24), Intermedics (n = 23), Medico (n = 13), Biotronik (n = 5). Intraoperative atrial endocavitary recording was 1.8 mV +/- 0.74. 17 patients died from a cause unrelated to pacemaker dysfunction. 4 patients were lost to follow-up. The remaining 44 patients were reviewed in our centre with a mean follow-up of 14.5 months +/- 7 months. Seven pacemakers (16%) were reprogrammed in VVI or VVI (R) mode, because of permanent atrial fibrillation in 3 cases, complete loss of atrial reception in 2 cases and late onset sinus dysfunction in 1 case. In the 41 patients in sinus atrial rhythm, the atrioventricular synchronization rate was greater than 90% in 88% of patients, equal to 76.3% in 2.4% of patients and atrioventricular synchronization was impossible in 9.6% of cases. CONCLUSION: The overall results of our preliminary experience of VDD mode single electrode pacemaker are moderate. The poor results essentially concerned patients with paroxysmal atrial arrhythmias prior to pacing.